| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12 |
| filingDate |
2013-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2016-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2016-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-104350049-B |
| titleOfInvention |
Substituted-amino quinazoline as inhibitors of kinases |
| abstract |
The invention discloses class novel quinazoline quinoline and its derivant, pharmaceutically acceptable salt, prodrug and a hydrate.These compounds of the present invention and and compositions there is protein kinase inhibiting activity and would be beneficial for the treatment of protein kinase mediated disease or disease. |
| priorityDate |
2012-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |